Shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) have been given a consensus recommendation of “Hold” by the eighteen analysts that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $42.53.
DOCS has been the subject of several recent research reports. Wells Fargo & Company boosted their price target on Doximity from $38.00 to $44.00 and gave the stock an “overweight” rating in a research report on Friday, November 11th. Piper Sandler dropped their price target on Doximity from $39.00 to $35.00 in a research note on Friday, November 11th. Evercore ISI boosted their price objective on Doximity from $28.00 to $32.00 in a report on Friday, November 11th. Truist Financial started coverage on Doximity in a report on Wednesday, September 7th. They issued a “hold” rating and a $35.00 price target for the company. Finally, BTIG Research began coverage on Doximity in a report on Thursday, October 13th. They issued a “neutral” rating for the company.
Institutional Trading of Doximity
Institutional investors have recently made changes to their positions in the stock. Parkside Financial Bank & Trust raised its stake in shares of Doximity by 225.2% in the 2nd quarter. Parkside Financial Bank & Trust now owns 813 shares of the company’s stock valued at $28,000 after purchasing an additional 563 shares in the last quarter. Castle Wealth Management LLC bought a new stake in Doximity during the second quarter worth approximately $31,000. Truvestments Capital LLC bought a new stake in Doximity during the second quarter worth approximately $32,000. Signaturefd LLC lifted its position in shares of Doximity by 98.1% in the 3rd quarter. Signaturefd LLC now owns 1,050 shares of the company’s stock valued at $32,000 after acquiring an additional 520 shares in the last quarter. Finally, Washington Trust Advisors Inc. lifted its position in shares of Doximity by 80.1% in the 2nd quarter. Washington Trust Advisors Inc. now owns 962 shares of the company’s stock valued at $33,000 after acquiring an additional 428 shares in the last quarter. 46.99% of the stock is owned by hedge funds and other institutional investors.
Doximity Stock Up 2.9 %
Shares of NASDAQ DOCS opened at $34.76 on Thursday. The business has a fifty day simple moving average of $29.24 and a two-hundred day simple moving average of $33.90. The firm has a market cap of $6.69 billion, a PE ratio of 53.48, a price-to-earnings-growth ratio of 18.31 and a beta of 0.91. Doximity has a twelve month low of $22.91 and a twelve month high of $64.95.
Doximity (NASDAQ:DOCS – Get Rating) last issued its earnings results on Thursday, November 10th. The company reported $0.12 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.12. The business had revenue of $102.19 million during the quarter, compared to analyst estimates of $99.86 million. Doximity had a return on equity of 16.41% and a net margin of 36.70%. On average, research analysts expect that Doximity will post 0.52 earnings per share for the current year.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.